We report a case of a 74-year-old male with locally advanced, HER-2 negative, mismatch repair-proficient, EBV-positive gastric adenocarcinoma, with high PD-L1 expression (CPS 69), who experienced disease progression during perioperative FLOT chemotherapy. This evidence concerns the gene ERBB2 and gastric adenocarcinoma.